Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers
Authors:
- William N RomWRWilliam N Rom
- Judith D GoldbergJGJudith D Goldberg
- Doreen Addrizzo-HarrisDADoreen Addrizzo-Harris
- Heather N WatsonHWHeather N Watson
- Michael KhilkinMKMichael Khilkin
- Alissa K GreenbergAGAlissa K Greenberg
- David P NaidichDNDavid P Naidich
- Bernard CrawfordBCBernard Crawford
- Ellen EylersEEEllen Eylers
- Daorong LiuDLDaorong Liu
- Eng M TanETEng M Tan
Open Access
- 26 May 2010
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 234
Abstract
Sera from lung cancer patients contain autoantibodies that react with tumor associated antigens (TAAs) that reflect genetic over-expression, mutation, or other anomalies of cell cycle, growth, signaling, and metabolism pathways.Keywords
This publication has 42 references indexed in Scilit:
- Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer SeraJournal of Clinical Oncology, 2008
- Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung AdenocarcinomaCancer Research, 2007
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningNew England Journal of Medicine, 2006
- Lung Cancer ScreeningNew England Journal of Medicine, 2005
- Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor‐associated antigensThe Prostate, 2005
- Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancerLung Cancer, 2004
- Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinomaInternational Journal of Cancer, 2002
- Cloning and characterization of a novel 90 kDa ‘companion’ auto-antigen of p62 overexpressed in cancerOncogene, 2002
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.Proceedings of the National Academy of Sciences, 1996